Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
33,773,100
-
Share change
-
-2,532,571
-
Total reported value
-
$284,706,913
-
Put/Call ratio
-
475%
-
Price per share
-
$8.43
-
Number of holders
-
111
-
Value change
-
-$83,075,336
-
Number of buys
-
72
-
Number of sells
-
45
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q4 2022
As of 31 Dec 2022,
Pulmonx Corp - COM (LUNG) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,773,100 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Champlain Investment Partners, LLC, BlackRock Inc., VANGUARD GROUP INC, MORGAN STANLEY, Point72 Asset Management, L.P., BRAIDWELL LP, PFM Health Sciences, LP, PURA VIDA INVESTMENTS, LLC, and KPCB XIII Associates, LLC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.